OptimizeRx
OPRX
13 hedge funds and large institutions have $21.3M invested in OptimizeRx in 2018 Q2 according to their latest regulatory filings, with 13 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
17.71% more ownership
Funds ownership: 0% → 17.71% (+18%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
+$7.65M |
| 2 |
PWAM
Park West Asset Management
San Francisco,
California
|
+$6.95M |
| 3 |
VCM
Venator Capital Management
Toronto,
Ontario, Canada
|
+$2.54M |
| 4 |
PCM
Perkins Capital Management
Wayzata,
Minnesota
|
+$1.61M |
| 5 |
AC
Avenir Corporation
Alexandria,
Virginia
|
+$693K |
Top Sellers
OPRX Hedge Fund Activity: Q2 2018 in Review
13 of the 4,385 institutional investors tracked by Wall St. Rank reported a position in OptimizeRx (OPRX) for Q2 2018, worth a combined $21.3M.
Buyers outnumbered sellers: 13 funds opened new OPRX positions and 0 closed out — a net gain of 13 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Wolverine Asset Management, opening a new position worth an estimated $7.65M.
- 13 institutional investors held OptimizeRx (OPRX) as of Q2 2018, up from 0 in Q1 2018.
- Funds reported $21.3M of OptimizeRx stock for Q2 2018.
- 13 funds opened new OptimizeRx positions in Q2 2018 and 0 closed out, a net change of +13 holders.
- The largest OptimizeRx buyer in Q2 2018 was Wolverine Asset Management, an estimated $7.65M added.
Based on aggregated 13F filings for Q2 2018.